Sign up and fund a new Wall St account and get a full U.S. share.Sign up and fund a new Wall St account and get a full share randomly chosen between GoPro, Dropbox or Nike.T&Cs apply
Prime Medicine, Inc. is a biotechnology company focused on developing genetic medicines designed to provide durable, and potentially curative, treatment options for patients with diseases driven by defined genetic alterations, acquired cellular dysfunction, or dysregulated gene expression. Its gene editing technology enables targeted modifications to genomic deoxyribonucleic acid (DNA) without introducing double-stranded breaks. The Company pipeline includes wholly owned in vivo programs targeting liver genetic diseases Wilson Disease, Alpha-1 Antitrypsin Deficiency (AATD) as well as early-stage discovery efforts in Cystic Fibrosis (CF). The PM359 is an ex vivo prime editing program designed to correct the GT mutation in the NCF1 gene, the most common cause of Chronic Granulomatous Disease (CGD). This program provides validation of prime editing in human cells. The Wilson Disease is a rare autosomal recessive disorder caused by loss-of-function mutations in ATP7B.
Find out what a historical investment in PRIME MEDICINE, INC. would be worth today using our PRME stock calculator.
Buying PRME shares in Australia can be done through an online investing platform, such as Stake. Follow the simple steps below to start investing in PRIME MEDICINE, INC. in minutes.
Sign up with some I.D. and zero paperwork
Add funds to your account
Make your first investment in PRME
What is the ticker symbol of PRIME MEDICINE, INC.?
The ticker symbol for PRIME MEDICINE, INC. is PRME.
How much is one share of PRME?
One share of PRME is valued at $3.84 as of 20 November 2026.
What is the market capitalisation of PRIME MEDICINE, INC. PRME?
As of 20 November 2026 PRIME MEDICINE, INC. has a market cap of $826.85M.
What is the 52-week high for PRIME MEDICINE, INC. stock?
The PRIME MEDICINE, INC. 52-week high stock price is $5.91.
What is the 52-week low for PRIME MEDICINE, INC. stock?
The PRIME MEDICINE, INC. 52-week low stock price is $2.67.
Can I buy PRME shares through Stake, an investing platform like CommSec, Selfwealth or Superhero?
Yes, the Stake investing platform allows you to buy PRME shares and over 13,000 more stocks and ETFs across the ASX and Wall St.
This is not financial product advice nor a recommendation to invest in the securities listed. Past performance is not a reliable indicator of future performance. As always, do your own research and consider seeking financial, legal and taxation advice before investing. No representation is made as to the timeliness, reliability, accuracy or completeness of the market data provided.
Invest in PRME on Stake
Buy PRME from US$3 brokerage
Invest in 11,000+ U.S. stocks and ETFs
Own a slice of PRME from only US$10 with fractional shares